8-KThe WireStrategic
Agreement Terminated
Filed Mar 29, 2023 · 3y ago · Accession 0001193125-23-082785
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Corvus Pharmaceuticals, Inc.
- Ticker
- CRVS
- CIK
- 1626971
- Form type
- 8-K
- Filing date
- Mar 29, 2023
- Report date
- Mar 28, 2023
- Document
- d483536d8k.htm
- Size
- 141 KB